Categories: New Launches

Lupin dispatches non specific Namenda XR capsuels in the US.

Mumbai, February 22, 2018: Pharma significant Lupin declared the dispatch of its Memantine Hydrochloride Broadened Discharge Containers, 7mg, 14mg, 21mg,28mg having gotten an endorsement from the Assembled States Sustenance and Medication Organization (FDA) prior.

Lupin’s Memantine Hydrochloride ER containers 7mg, 14mg, 21mg, 28mg are the nonexclusive counterparts of Allergan’s Namenda XR capsiles.

It is demonstrated for the treatment of direct to serious dementia of the Alzheimer’s write. Memantine Hydrochloride ER cases 7mg, 14mg, 21mg, 28mg had yearly offers of roughly USD 936 million in the US.

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago